November 27, 2018
ECO Animal Health, University of Georgia sign poultry vaccine development deal
ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, announced in mid-November that it has entered into a licensing deal with the Poultry Diagnostic & Research Center (College of Veterinary Medicine) at the University of Georgia (UGA).
This deal, at a cost of just over $1 million in phased payments of eight quarterly instalments over a two-year period, allows the UK-based ECO to license research-related innovations leading to the development of potential vaccines in the field of Mycoplasma gallisepticum, a bacterium that can cause severe respiratory disease in poultry.
A joint steering committee will meet monthly to review data, monitor progress and make decisions.
Peter Lawrence, chairman of ECO Animal Health Group plc, said: "Mycoplasma-related illnesses in poultry can be financially devastating to commercial poultry producers with global losses estimated at more than GBP500 million (US$641 million) annually. We are delighted to have entered into this collaboration with UGA and expect that further innovative developments will follow".
"Although Mycoplasma control programmes are often based on biosecurity, early detection, quarantine and elimination of positive flocks, vaccination can be a very effective option in some circumstances," Professor Naola Ferguson-Noel, a researcher in the Poultry Diagnostic and Research Center, commented.
"I do think a vaccine is within reach."
- ECO Animal Health Groupa